Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
J Immunol. 2011 Sep 15;187(6):3026-32. doi: 10.4049/jimmunol.1101262. Epub 2011 Aug 15.
EBV-induced gene 2 (EBI2) was recently shown to direct the delayed movement of activated B cells to interfollicular and outer follicular regions of secondary lymphoid organs and to be required for mounting a normal T-dependent Ab response. In this study, we show that EBI2 promotes an early wave of Ag-activated B cell migration to the outer follicle in mice. Later, when B cells have moved to the T zone in a CCR7-dependent manner, EBI2 helps distribute the cells along the B zone-T zone boundary. Subsequent EBI2-dependent movement to the outer follicle coincides with CCR7 downregulation and is promoted by CD40 engagement. Using a bioassay, we identify a proteinase K-resistant, hydrophobic EBI2 ligand activity in lymphoid and nonlymphoid tissues. Production of EBI2 ligand activity by a cell line is sensitive to statins, suggesting production in a 3-hydroxy-3-methyl-glutaryl-CoA reductase-dependent manner. CD40-activated B cells show sustained EBI2-dependent responsiveness to the bioactivity. These findings establish a role for EBI2 in helping control B cell position at multiple stages during the Ab response and they suggest that EBI2 responds to a broadly distributed lipid ligand.
EBV 诱导基因 2(EBI2)最近被证明指导激活 B 细胞向次级淋巴器官的滤泡间和滤泡外区域的延迟运动,并需要正常的 T 依赖性抗体反应。在这项研究中,我们表明 EBI2 促进了抗原激活的 B 细胞向小鼠滤泡外的早期迁移波。之后,当 B 细胞以 CCR7 依赖性的方式迁移到 T 区时,EBI2 有助于沿着 B 区-T 区边界分布细胞。随后依赖 EBI2 的向滤泡外的运动与 CCR7 下调一致,并受 CD40 结合的促进。使用生物测定法,我们在淋巴组织和非淋巴组织中鉴定到一种蛋白水解酶抗性、疏水性的 EBI2 配体活性。细胞系产生 EBI2 配体活性对他汀类药物敏感,提示其以 3-羟基-3-甲基戊二酰辅酶 A 还原酶依赖性的方式产生。CD40 激活的 B 细胞对生物活性表现出持续的 EBI2 依赖性反应性。这些发现确立了 EBI2 在帮助控制抗体反应过程中 B 细胞位置的多个阶段中的作用,并表明 EBI2 对广泛分布的脂质配体做出反应。